← Back to patent-cliff list
Diphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor
Tier C — Watch / tradeDiphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor
-
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：HRH1, SCNA, TRPM8
Indications (approved)：Pruritus, Atopic dermatitis
Regional status
US
-
EU
-
China
Approved
1996-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Diphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor?
Approved indications include: Pruritus, Atopic dermatitis.
When does the Diphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor patent expire?
No public expiry year is available for Diphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor yet; this page updates once verified.
How do I get a quote for Diphenhydramine Hydrochloride/Benzocaine/Menthol/Camphor intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04